Ocular Immunology And Uveitis Foundation Inc
Ocular Immunology And Uveitis Foundation Inc shows strong financial growth and no officer compensation.
EIN: 201891037 · Weston, MA · NTEE: H41 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $1.9M |
| Total Expenses | $705K |
| Program Spending | 85% |
| Net Assets | $2.1M |
| Transparency Score | 90/100 |
Is Ocular Immunology And Uveitis Foundation Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Ocular Immunology And Uveitis Foundation Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Ocular Immunology And Uveitis Foundation Inc
Ocular Immunology And Uveitis Foundation Inc (EIN: 201891037) is a nonprofit organization based in Weston, MA, classified under NTEE code H41. The organization reported total revenue of $1.9M and total assets of $3.0M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Ocular Immunology And Uveitis Foundation Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Ocular Immunology And Uveitis Foundation Inc is a mid-size nonprofit that has been operating for 20 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 5.5%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.6M |
| Total Expenses | $705K |
| Surplus / Deficit | +$934K |
| Total Assets | $2.2M |
| Total Liabilities | $122K |
| Net Assets | $2.1M |
| Operating Margin | 57.0% |
| Debt-to-Asset Ratio | 5.5% |
| Months of Reserves | 38.0 months |
Financial Health Grade: A
In 2023, Ocular Immunology And Uveitis Foundation Inc reported a surplus of $934K with revenue exceeding expenses, holds 38.0 months of operating reserves (strong position), has a debt-to-asset ratio of 5.5% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Ocular Immunology And Uveitis Foundation Inc's revenue has grown at a compound annual growth rate (CAGR) of 5.5%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +123.4% | -4.0% | +106.6% |
| 2022 | +8.6% | +12.8% | -16.8% |
| 2021 | +26.4% | +18.0% | +8.4% |
| 2020 | -13.0% | -29.4% | +9.1% |
| 2019 | -48.0% | -46.5% | -16.8% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2006 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Ocular Immunology And Uveitis Foundation Inc with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Ocular Immunology And Uveitis Foundation Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $934K, with revenue exceeding expenses.
- Debt-to-asset ratio: 5.5%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filing periods, indicating that the organization's officers are not receiving salaries. This is a highly positive indicator, suggesting a strong commitment to directing all available funds towards the organization's mission rather than administrative overhead for leadership.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for Ocular Immunology And Uveitis Foundation Inc:
- Consistent 0% officer compensation across all filings, indicating strong dedication to mission.
- Significant revenue growth, particularly from $733,623 in 2022 to $1,638,698 in 2023.
- Substantial increase in assets, growing from $1,079,830 in 2022 to $2,230,654 in 2023.
- Expenses consistently lower than revenue in recent periods, demonstrating financial efficiency.
- Low liabilities relative to assets, indicating strong financial stability.
Frequently Asked Questions about Ocular Immunology And Uveitis Foundation Inc
Is Ocular Immunology And Uveitis Foundation Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Ocular Immunology And Uveitis Foundation Inc (EIN: 201891037) appears legitimate. Mission Score: 90/100. 0 red flags identified, 5 strengths noted.
How does Ocular Immunology And Uveitis Foundation Inc spend its money?
Ocular Immunology And Uveitis Foundation Inc directs 85% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Ocular Immunology And Uveitis Foundation Inc tax-deductible?
Ocular Immunology And Uveitis Foundation Inc is registered as a tax-exempt nonprofit (EIN: 201891037). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Ocular Immunology And Uveitis Foundation Inc's spending goes to programs?
Ocular Immunology And Uveitis Foundation Inc directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Ocular Immunology And Uveitis Foundation Inc compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), Ocular Immunology And Uveitis Foundation Inc is above average for NTEE category H41 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Ocular Immunology And Uveitis Foundation Inc located?
Ocular Immunology And Uveitis Foundation Inc is headquartered in Weston, Massachusetts and files with the IRS under EIN 201891037. It is classified under NTEE code H41.
How many years of IRS 990 filings does Ocular Immunology And Uveitis Foundation Inc have?
Ocular Immunology And Uveitis Foundation Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.9M in total revenue.
Is Ocular Immunology And Uveitis Foundation Inc a good charity?
Based on the provided financial data, Ocular Immunology And Uveitis Foundation Inc appears to be a good charity. It demonstrates strong financial health with growing assets and revenue, low liabilities, and a notable commitment to not paying officer compensation, suggesting efficient use of funds for its mission.
How has the organization's financial health changed over time?
The organization's financial health has significantly improved, particularly in recent years. Revenue has grown from $534,488 in 2020 to $1,638,698 in 2023, and assets have more than doubled from $1,079,830 in 2022 to $2,230,654 in 2023, indicating robust growth and stability.
What is the trend in expenses relative to revenue?
In recent years, the organization has shown a positive trend where revenue significantly outpaces expenses. For example, in 2023, revenue was $1,638,698 while expenses were $704,660, resulting in a substantial surplus. This indicates strong financial management and efficiency.
Filing History
IRS 990 filing history for Ocular Immunology And Uveitis Foundation Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Ocular Immunology And Uveitis Foundation Inc's revenue has grown by 90.1%, moving from $862K to $1.6M. Total assets increased by 101.2% over the same period, from $1.1M to $2.2M. Total functional expenses fell by 11.9%, from $800K to $705K. In its most recent filing year (2023), Ocular Immunology And Uveitis Foundation Inc reported a surplus of $934K, with revenue exceeding expenses. The organization holds $122K in liabilities against $2.2M in assets (debt-to-asset ratio: 5.5%), resulting in net assets of $2.1M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $1.6M | $705K | $2.2M | $122K | — | — |
| 2022 | $734K | $734K | $1.1M | $69K | — | View 990 |
| 2021 | $676K | $651K | $1.3M | $52K | — | View 990 |
| 2020 | $534K | $551K | $1.2M | $31K | — | — |
| 2019 | $615K | $781K | $1.1M | $30K | — | View 990 |
| 2018 | $1.2M | $1.5M | $1.3M | $150K | — | View 990 |
| 2017 | $1.1M | $1.3M | $1.8M | $200K | — | View 990 |
| 2016 | $1.1M | $1.0M | $1.7M | $20K | — | View 990 |
| 2015 | $1.1M | $895K | $1.6M | $34K | — | View 990 |
| 2014 | $1.3M | $811K | $1.5M | $18K | — | View 990 |
| 2013 | $732K | $938K | $1.1M | $27K | — | View 990 |
| 2012 | $908K | $872K | $1.2M | $17K | — | View 990 |
| 2011 | $862K | $800K | $1.1M | $35K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.6M, expenses of $705K, and assets of $2.2M (revenue +123.4% year-over-year).
- 2022: Revenue of $734K, expenses of $734K, and assets of $1.1M (revenue +8.6% year-over-year).
- 2021: Revenue of $676K, expenses of $651K, and assets of $1.3M (revenue +26.4% year-over-year).
- 2020: Revenue of $534K, expenses of $551K, and assets of $1.2M (revenue -13.0% year-over-year).
- 2019: Revenue of $615K, expenses of $781K, and assets of $1.1M (revenue -48.0% year-over-year).
- 2018: Revenue of $1.2M, expenses of $1.5M, and assets of $1.3M (revenue +6.8% year-over-year).
- 2017: Revenue of $1.1M, expenses of $1.3M, and assets of $1.8M (revenue +1.5% year-over-year).
- 2016: Revenue of $1.1M, expenses of $1.0M, and assets of $1.7M (revenue +2.6% year-over-year).
- 2015: Revenue of $1.1M, expenses of $895K, and assets of $1.6M (revenue -15.9% year-over-year).
- 2014: Revenue of $1.3M, expenses of $811K, and assets of $1.5M (revenue +72.6% year-over-year).
- 2013: Revenue of $732K, expenses of $938K, and assets of $1.1M (revenue -19.4% year-over-year).
- 2012: Revenue of $908K, expenses of $872K, and assets of $1.2M (revenue +5.4% year-over-year).
- 2011: Revenue of $862K, expenses of $800K, and assets of $1.1M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Ocular Immunology And Uveitis Foundation Inc:
Data Sources and Methodology
This transparency report for Ocular Immunology And Uveitis Foundation Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.